Skip to main content
Premium Trial:

Request an Annual Quote

Genetic Technologies Names New Chairman, Acting CEO

NEW YORK (GenomeWeb News) – A day after its chairman's re-election was blocked and its CEO resigned, Genetic Technologies named a new chairman and acting CEO today.

The Australian firm named Mal Brandon, a current board member, as its new chairman of the board of directors. The firm also said that COO Alison Mew has been named acting CEO.

The appointments come a day after the firm's annual general meeting, at which Chairman Mel Bridges and Director Huw Jones were not re-elected to the firm's board — apparently due to the efforts of Founder Mervyn Jacobson, who used his 29 percent stake to block their re-election. Following the meeting, CEO Paul MacLeman, Director Greg Brown, and VP of Legal and Corporate Development David Sparling all resigned.

The firm did not respond to an email from GenomeWeb Daily News seeking further information and comment.

"The board is confident that the company will continue to build on the solid foundation that has been created and looks forward to further expansion of its US operations and its global licensing programs," Brandon said in a statement issued today.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.